
Keywords: N-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; Neurodegeneration; Flavonoids; Antioxidant; Signalling pathways; Neuroinflammation; AD; Alzheimer's disease; PD; Parkinson's disease; HD; Huntington's disease; ALS; amyotrophic lateral sclerosis; MS; multiple sclerosis; DA; dopamine agonist; IFN; interfer